Centinel Spine® Refinances Existing Senior Secured Term Loan Facility with SLR Capital Partners

WEST CHESTER, Pa., Feb. 26, 2025 /PRNewswire/ -- Centinel Spine®, LLC ("the Company"), the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), today announced that is has entered into a senior secured loan agreement with credit funds managed by SLR Capital Partners, LLC ("SLR") to provide the Company with $60 million of capital at close and the ability to draw down up to $10 million in additional capital. The proceeds from the initial funding of the term loan will be used to retire the Company's existing credit facility, pay related fees and expenses, and provide additional working capital.

According to Centinel Spine CFO Varun Gandhi, "We are very pleased with the outcome of this refinancing transaction with SLR. This upsized facility with favorable terms provides Centinel Spine with greater flexibility to continue to invest in the growth of its business. The Company has made meaningful progress with its motion preservation business—with revenues more than doubling from 2022 to 2024, along with 7 quarters of adjusted EBITDA positive performance. We are pleased that our partner, SLR, believes in our strategy and ability to execute and is willing to further support our growing enterprise."

"SLR is excited to leverage our investment expertise in the life science sector by partnering with Centinel Spine to support their development and commercialization efforts in treating cervical and lumbar spine disease with their total disc replacement technology platform," said Anthony Storino, Partner and Head of Life Science Finance at SLR Capital Partners.

Commenting further, Centinel Spine CEO Steve Murray notes, "Our Match-the-Disc^™ portfolio for cervical and lumbar motion preservation is clearly resonating with the surgeon community, as evidenced by our strong 4Q and FY 2024 results. This refinancing will position the Company to continue to drive expanded portfolio differentiation, long-term profitable sales, and deliver on our mission to be the leading total disc replacement company in the world."

About Centinel Spine, LLC

Centinel Spine®, LLC is the leading global medical device company exclusively focused on addressing cervical and lumbar spinal disease with prodisc®, the most complete total disc replacement (TDR) technology platform in the world.

The Company's prodisc technology is the most studied and clinically-proven TDR system across the globe, validated by over 540 published papers and more than 275,000 implantations. Centinel Spine's prodisc is the only TDR technology with multiple motion-preserving anatomic solutions, allowing the surgeon to Match-the-Disc^™ to each patient's anatomy for both cervical and lumbar total disc replacement.

For more information, please visit the company's website at www.CentinelSpine.com or contact:

Varun Gandhi
Chief Financial Officer
900 Airport Road, Suite 3B
West Chester, PA 19380
Phone: 484-887-8871
Email: [email protected] 

About SLR Capital Partners

Founded in 2006, SLR is a diversified middle market private credit solutions platform. The firm is an SEC-registered investment adviser and primarily invests in U.S. middle market companies in the form of cash flow, asset-based, and specialty finance senior secured loans. SLR manages public and private business development companies ("BDCs"), private credit funds, and separately managed accounts. The SLR Capital Partners Life Science Finance business provides financing solutions for later-stage bio-pharma, medical device, diagnostics, healthcare IT, and healthcare services companies, both venture-backed private and public, and from pre-revenue clinical to early commercial stage. For more information, please visit:

https://www.slrcapitalpartners.com/Financial-Solutions/Life-Science-Finance.

SOURCE Centinel Spine, LLC